Status:
UNKNOWN
Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors
Lead Sponsor:
Assiut University
Conditions:
Bone Tumor
Eligibility:
All Genders
1-100 years
Brief Summary
Percutaneous vertebroplasty is a new technique to strengthen bone and reduce pain for patients with vertebral tumors
Detailed Description
Destructive vertebral lesions are a common in metastatic disease, multiple myeloma and lymphoma. Symptoms are caused by pathologic fracture consequences secondary to vertebral destruction, development...
Eligibility Criteria
Inclusion
- Spinal instability
- Pain with movement
- Multiple level involvement
- Expected survival 3-6 months
Exclusion
- Absolute
- Asymptomatic
- improving on medical treatment without worsening of the collapse.
- infection local or systemic
- uncorrectable coagulopathy
- Allergy to bone cement or contrast media
- Relative
- Radicular pain
- Tumor extension inside the vertebral canal or cord compression
- Fracture of the posterior column
- Sclerotic metastasis
- Diffuse metastases
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03427632
Start Date
March 1 2018
End Date
March 1 2019
Last Update
February 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University hospital
Asyut, Egypt, 71515